Neurones Total Assets

Latest as of December 2025: €749.03 Million EUR ≈ $875.70 Million USD

Neurones total assets. Based on the latest financial reports, Neurones (NRO) holds total assets worth €749.03 Million EUR (≈ $875.70 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see NRO market cap for the company's overall valuation and market capitalisation.

Total Assets of Neurones (2000–2025)

Total assets of Neurones from 2000 to 2025. This chart illustrates how Neurones's total assets have evolved over time, based on quarterly financial data. See Neurones share price for real-time trading data and today's change.

Neurones - Asset Composition Analysis

Neurones Total Assets Breakdown (December 2025)

Neurones total assets breakdown as of December 2025. Neurones's total assets of €749.03 Million consist of 81.2% current assets and 18.8% non-current assets.

Asset Category	Amount (EUR)	% of Total Assets
Cash & Equivalents	€0.00	45.5%
Accounts Receivable	€248.92 Million	33.2%
Inventory	€700.00K	0.1%
Property, Plant & Equipment	€0.00	0.0%
Intangible Assets	€1.77 Million	0.2%
Goodwill	€60.93 Million	8.1%

Asset Composition Trend (2000–2025)

This chart illustrates how Neurones's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Neurones (NRO) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Neurones's current assets represent 81.2% of total assets in 2025, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 45.5% of total assets in 2025, up from 17.6% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 16.0% in 2000.
Asset Diversification: The largest asset category is accounts receivable at 33.2% of total assets.

Neurones Competitors by Total Assets

Key competitors of Neurones based on total assets are shown below.

Company	Country	Total Assets
Wise Group plc Class A Ordinary Shares NASDAQ:WSE	USA	$19.25 Billion
GDS HLDGS LTD DL-00005 F:G401	Germany	€85.79 Billion
Cipher Mining Inc NASDAQ:CIFR	USA	$7.50 Billion
Shanghai AtHub Co Ltd SHG:603881	China	CN¥7.35 Billion
Hand Enterprise Solutions Co SHE:300170	China	CN¥6.48 Billion
ArcSoft Corp Ltd SHG:688088	China	CN¥3.03 Billion
Beijing Lanxum Tech Co SHE:300010	China	CN¥2.61 Billion
Beijing Thunisoft Co Ltd SHE:300271	China	CN¥4.58 Billion

Neurones - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.43	2.33	2.78
Quick Ratio	2.43	2.33	2.77
Cash Ratio	0.00	0.00	0.00
Working Capital	€358.47 Million	€335.46 Million	€287.64 Million

Neurones - Advanced Valuation Insights

This section examines the relationship between Neurones's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.39
Latest Market Cap to Assets Ratio	1.18
Asset Growth Rate (YoY)	3.2%
Total Assets	€749.03 Million
Market Capitalization	$885.97 Million USD

Valuation Analysis

Above Book Valuation: The market values Neurones's assets above their book value (1.18x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Neurones's assets grew by 3.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Neurones (2000–2025)

The table below shows the annual total assets of Neurones from 2000 to 2025.

Year	Total Assets	Change
2025-12-31	€749.03 Million ≈ $875.70 Million	+3.22%
2024-12-31	€725.69 Million ≈ $848.41 Million	+7.63%
2023-12-31	€674.25 Million ≈ $788.27 Million	+9.42%
2022-12-31	€616.22 Million ≈ $720.42 Million	+8.52%
2021-12-31	€567.82 Million ≈ $663.84 Million	+3.27%
2020-12-31	€549.85 Million ≈ $642.83 Million	+7.78%
2019-12-31	€510.14 Million ≈ $596.40 Million	+13.60%
2018-12-31	€449.06 Million ≈ $524.99 Million	+9.08%
2017-12-31	€411.69 Million ≈ $481.31 Million	+6.76%
2016-12-31	€385.63 Million ≈ $450.84 Million	+9.81%
2015-12-31	€351.20 Million ≈ $410.59 Million	+15.46%
2014-12-31	€304.17 Million ≈ $355.60 Million	+9.13%
2013-12-31	€278.72 Million ≈ $325.85 Million	+11.49%
2012-12-31	€250.00 Million ≈ $292.27 Million	+10.88%
2011-12-31	€225.47 Million ≈ $263.59 Million	+18.69%
2010-12-31	€189.96 Million ≈ $222.09 Million	+12.37%
2009-12-31	€169.05 Million ≈ $197.63 Million	+2.06%
2008-12-31	€165.64 Million ≈ $193.65 Million	+22.26%
2007-12-31	€135.48 Million ≈ $158.39 Million	+14.56%
2006-12-31	€118.26 Million ≈ $138.26 Million	+17.26%
2005-12-31	€100.85 Million ≈ $117.90 Million	+8.36%
2004-12-31	€93.07 Million ≈ $108.81 Million	+13.12%
2003-12-31	€82.28 Million ≈ $96.19 Million	+4.32%
2002-12-31	€78.87 Million ≈ $92.21 Million	+5.88%
2001-12-31	€74.49 Million ≈ $87.09 Million	+19.43%
2000-12-31	€62.37 Million ≈ $72.92 Million	--

About Neurones

PA:NRO France Information Technology Services

Market Cap

$1.09 Billion

€931.47 Million EUR

Market Cap Rank

#9137 Global

#145 in France

Share Price

€38.90

Change (1 day)

+0.91%

52-Week Range

€33.65 - €44.70

All Time High

€51.10